De-escalation (of numbers of drugs as well as dosages) is shaping up to be a major theme in #oncology, beginning with @sabcs.bsky.social coming up next month. Colleagues in #breastcancer leading the way, maybe more to come for GI cancers at #GI25, and even more at #ASCO25?
Reposted from
Ajay Prakash, MD, PhD
De-escalation based clinical trials are critical to safe medical care.
Comments